Skip to main content
IDWeek 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

Joshua A. Hill, MD

Associate Professor
Fred Hutchinson Cancer Center; University of Washington
Seattle, WA, United States

Dr. Joshua A. Hill is an Associate Professor at the Fred Hutchinson Cancer Center (FHCC) and the University of Washington (UW). His research program is focused on clinical and translational studies to improve preventive and treatment strategies for infections in patients receiving hematopoietic cell transplantations (HCT) and CAR-T cell therapies. Dr. Hill trained in Transplant Infectious Diseases at FHCC and epidemiology/biostatics at the Harvard School of Public Health. He serves as an attending physician on the Immunocompromised Host Infectious Diseases Service at the FHCC and UW Medical Center.

Disclosure(s): AlloVir: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Century Therapeutics, Inc: Advisor/Consultant (Terminated, May 31, 2023); CSL Behring: Advisor/Consultant (Ongoing); Deverra: Grant/Research Support (Ongoing); GeoVax: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Gilead Australia: Advisor/Consultant (Terminated, February 28, 2024); Karius: Advisor/Consultant (Ongoing); Merck: Grant/Research Support (Ongoing); Moderna: Board Member (Terminated, January 6, 2024); Modulus: Advisor/Consultant (Ongoing); Oxford Immunotec: Grant/Research Support (Ongoing); Senti BioSciences, Inc: Advisor/Consultant (Ongoing); Takeda: Advisor/Consultant (Terminated, December 31, 2022); Up-to-Date: Advisor/Consultant (Terminated, June 7, 2023)

Presentation(s):